IL30594A - Pharmaceutical preparations containing salts of astron sulphate and of estradiol and sulphate are used especially in case of disorders during the crisis - Google Patents

Pharmaceutical preparations containing salts of astron sulphate and of estradiol and sulphate are used especially in case of disorders during the crisis

Info

Publication number
IL30594A
IL30594A IL30594A IL3059468A IL30594A IL 30594 A IL30594 A IL 30594A IL 30594 A IL30594 A IL 30594A IL 3059468 A IL3059468 A IL 3059468A IL 30594 A IL30594 A IL 30594A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
sulphate
salts
salt
compositions according
Prior art date
Application number
IL30594A
Other languages
English (en)
Hebrew (he)
Other versions
IL30594A0 (en
Original Assignee
Merck Ag E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19671617654 external-priority patent/DE1617654A1/de
Application filed by Merck Ag E filed Critical Merck Ag E
Publication of IL30594A0 publication Critical patent/IL30594A0/xx
Publication of IL30594A publication Critical patent/IL30594A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL30594A 1967-10-19 1968-08-21 Pharmaceutical preparations containing salts of astron sulphate and of estradiol and sulphate are used especially in case of disorders during the crisis IL30594A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19671617654 DE1617654A1 (de) 1967-10-19 1967-10-19 Arzneimittel

Publications (2)

Publication Number Publication Date
IL30594A0 IL30594A0 (en) 1968-10-24
IL30594A true IL30594A (en) 1972-05-30

Family

ID=5682283

Family Applications (1)

Application Number Title Priority Date Filing Date
IL30594A IL30594A (en) 1967-10-19 1968-08-21 Pharmaceutical preparations containing salts of astron sulphate and of estradiol and sulphate are used especially in case of disorders during the crisis

Country Status (9)

Country Link
US (1) US3639599A (pt)
BE (1) BE722511A (pt)
BR (1) BR6803213D0 (pt)
DK (1) DK120812B (pt)
ES (1) ES359336A1 (pt)
FR (1) FR7983M (pt)
GB (1) GB1175468A (pt)
IL (1) IL30594A (pt)
SE (1) SE365408B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2645307A1 (de) * 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
US4145416A (en) * 1976-06-23 1979-03-20 Schering, A.G. Novel agents and novel methods for treatment of climacteric disturbances
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤
US4946679A (en) * 1988-07-25 1990-08-07 Thys Jacobs Susan Method for the treatment of premenstrual syndrome
US5354743A (en) 1992-09-15 1994-10-11 Thys Jacobs Susan Method for the treatment of premenstrual syndrome with vitamin D
US20020173499A1 (en) * 2001-03-16 2002-11-21 Wyeth Estrogen replacement therapy
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
JP2009521533A (ja) * 2005-12-27 2009-06-04 デュラメド ファーマシューティカルズ インコーポレーティッド 結合型エストロゲン組成物、アプリケーター、キット、ならびにそれらの作製および使用の方法
WO2008100769A2 (en) * 2007-02-09 2008-08-21 Wyeth Process for selective sulfation of aromatic hydroxyl groups

Also Published As

Publication number Publication date
SE365408B (pt) 1974-03-25
US3639599A (en) 1972-02-01
ES359336A1 (es) 1970-07-01
FR7983M (pt) 1970-06-08
BR6803213D0 (pt) 1973-04-26
DK120812B (da) 1971-07-19
IL30594A0 (en) 1968-10-24
GB1175468A (en) 1969-12-23
BE722511A (pt) 1969-04-18

Similar Documents

Publication Publication Date Title
US4154820A (en) Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
IL30594A (en) Pharmaceutical preparations containing salts of astron sulphate and of estradiol and sulphate are used especially in case of disorders during the crisis
KR890001001B1 (ko) 안정화된 피록시캄 주사용액의 제조방법
FI98984C (fi) Ehkäisyvalmiste, joka sisältää ainoastaan progestogeenia
TW457089B (en) Pharmaceutical composition for treating or inhibiting the growth of tumors or cancers susceptible to treatment
GB1595185A (en) Contraceptive compositions
DK141354B (da) To-trinskombinationspraeparat til oral svangerskabsforebyggelse
AU598282B2 (en) Solutions of oxazaphosphorins having improved stability and process for the preparation thereof
EP0208519A2 (en) Solubilized composition of hardly-soluble pharmaceutical product
US2970944A (en) Parenteral solutions of steroid phosphates stabilized with creatinines
Azzopardi et al. Synthetic progestogen-oestrogen therapy and uterine changes
US4439451A (en) Treatment of the blood-brain barrier with flurbiprofen
US4171358A (en) Novel contraceptive method
PT94493A (pt) Processo para a preparacao de composicoes uteis como contraceptivos em machos a base de melatonina e de uma hormona androgenica
US4443476A (en) Treatment of adult respiratory distress syndrome
EP0180303B1 (en) Parenteral composition
Poirier et al. Dietary induction of some enzymes of amino acid metabolism during azo dye feeding
IL21955A (en) Salts of fusidic acid and antibiotics of the tetracycline series
US3322627A (en) Method of treating herpes simplex infections with 5-methylamino-2'-deoxyuridine, and compositions therefor
GB2105988A (en) Anti-platelet aggregation dipyridamole with Al aspirin
Land et al. The effect of selected antineoplastic agents on the morphology of Candida albicans 5865
US3270024A (en) Heterocyclic amino phenoxyacetic acid amides, acid addition salts, and quaternary ammonium salts thereof
US2598004A (en) Stabilized tetrathiodilactic and tetathiodiglycollic acid pharmaceutical
US3497497A (en) Amino acid salts of hexose-phosphates
Gray et al. Aureomycin absorption and distribution in the gastro-intestinal tract of the dog